DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	ARID1A; FOS; TNF; HLA-DRB1; CD74; TFAP2A; IRF1; CDH1; TCF4; ELF1; SOX2; CTCF; MECP2; HCFC1; EP300; NFATC2; RUNX3; NCOA6; ZFHX3; HMBOX1; KMT2E; ZNF398; ESR2; RREB1; CREBBP; SMARCC1; NSD1; CDK5RAP2; EPC1; PIM2; PRDM2;	GO:0045893~positive regulation of transcription, DNA-templated	31	570	5.43859649122807	0	0	0	0	0	0	0
down	WWP2; TET3; FOS; TNF; RAF1; TFAP2A; IRF1; HCLS1; TCF4; ELF1; SREBF1; SOX2; FLT3LG; EP300; BPTF; PRDM2; FZD5; CAMK1; NCOA6; ZFHX3; ZBTB49; DOT1L; MAML1; RREB1; CREBBP; SMARCC1; RGMA; MAML3; RBM14; EPC1; ASH1L; INO80; ZMIZ1; PLAGL2; SOX21; GMEB1; CTCF; NCOA2; NFATC2; TCF20;	GO:0045944~positive regulation of transcription by RNA polymerase II	40	1138	3.51493848857645	0	0	0	0	0	0	0
down	HCLS1; PREX1; COTL1; DBNL;	GO:0030833~regulation of actin filament polymerization	4	24	16.6666666666667	0.00011466074997124	0.0046381718389964	0.229092178442538	0.234710555191129	0.174857643706142	0.229092178442538	0.0380403860483318
down	CCDC88B; TNF; EIF2AK2; TMIGD2;	GO:0001819~positive regulation of cytokine production	4	25	16	0.00013205644833624	0.00510036886310001	0.263452614430816	0.270319549744301	0.189897172707525	0.263452614430816	0.0418311367659887
down	EP300; MAML1; CREBBP; MAML3; ZMIZ1;	GO:0045747~positive regulation of Notch signaling pathway	5	50	10	0.00014330333169076	0.00543225777724084	0.285746843391394	0.293341919971005	0.199349987708162	0.285746843391394	0.044553153728131
down	DIAPH1; ERBB2; APC;	GO:0032886~regulation of microtubule-based process	3	9	33.3333333333333	0.00015294378811114	0.0056922897138822	0.304816969705519	0.313075934263521	0.207293857331007	0.304816969705519	0.0466858291869326
down	TNF; HLA-DRB1; CD74; ERBB2; CSF1R; FLT3LG; PRR5L; CARD14;	GO:0001934~positive regulation of protein phosphorylation	8	161	4.96894409937888	0.0001680747194569	0.00595184993307713	0.33463676643869	0.344048950728276	0.218361004526726	0.33463676643869	0.0488146358124115
down	LTA; TNF; PSMB9; PSMB10; PLVAP; CARD14; TNFSF13B;	GO:0033209~tumor necrosis factor-mediated signaling pathway	7	120	5.83333333333333	0.00016864059409793	0.00595184993307713	0.335594782254891	0.345207296118473	0.218796834659655	0.335594782254891	0.0488146358124115
down	XRCC2; SP2; NOTCH2; EP300; PPP1R13L; SMPD3;	GO:0035264~multicellular organism growth	6	84	7.14285714285714	0.00017574412402365	0.00609742748943098	0.349555062683056	0.359748221876428	0.224040064146301	0.349555062683056	0.0500086033142433
down	PIK3CD; TNF; ERBB2; LCK; HCLS1; AREG; STOX1; AXL;	GO:0051897~positive regulation of protein kinase B signaling	8	165	4.84848484848485	0.00019718373609145	0.00672725179632015	0.392001267349813	0.403635107779209	0.239773528448878	0.392001267349813	0.0551741643603539
down	CDH1; SOX2; CRIP1; TCIRG1; STOX1; ZNF507; ZNF407; TCF19;	GO:0010468~regulation of gene expression	8	166	4.81927710843374	0.00020507281295256	0.00688170570678532	0.407479679336751	0.419784048113905	0.244651865852412	0.407479679336751	0.0564409320836561
down	TNF; RAF1; HCLS1; CAMK1; STOX1; HDAC6;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	6	88	6.81818181818182	0.00022294134264044	0.00724382426007932	0.44276150648393	0.456360928384997	0.255490778665953	0.442538565141289	0.0594108801668103
down	PSMB9; PSMB10; TIAM1; FZD5; SMURF1; CELSR2;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	6	88	6.81818181818182	0.00022294134264044	0.00724382426007932	0.44276150648393	0.456360928384997	0.255490778665953	0.442538565141289	0.0594108801668103
down	ZBTB42; ADGRB1; CHD2; ZFHX3; JPH1; ITGB1BP2;	GO:0007517~muscle organ development	6	89	6.74157303370786	0.00023616900597667	0.00740655242777151	0.468559307857717	0.483437955234247	0.263564610669966	0.468559307857717	0.0607455099595021
down	GAS8; CASP2; BPTF; NCOA6; CDK5RAP2; SLC23A1; ADGRG1; ZFHX3; SYNJ2;	GO:0007420~brain development	9	217	4.14746543778802	0.00024492863974767	0.00740655242777151	0.485693492619643	0.501368925563495	0.268931646442949	0.485693492619643	0.0607455099595021
down	MCM2; MCM3; CDC45;	GO:0000727~double-strand break repair via break-induced replication	3	11	27.2727272727273	0.00024965907059904	0.00740655242777151	0.494824277927297	0.511052117516234	0.271878727882354	0.4940753007155	0.0607455099595021
down	IFIT3; IFIT2; AXL;	GO:0035457~cellular response to interferon-alpha	3	11	27.2727272727273	0.00024965907059904	0.00740655242777151	0.494824277927297	0.511052117516234	0.271878727882354	0.4940753007155	0.0607455099595021
down	ARID1A; PADI2; ZMIZ1;	GO:0048096~chromatin-mediated maintenance of transcription	3	11	27.2727272727273	0.00024965907059904	0.00740655242777151	0.494824277927297	0.511052117516234	0.271878727882354	0.4940753007155	0.0607455099595021
down	EPHA4; RGMA; KREMEN1;	GO:0048681~negative regulation of axon regeneration	3	11	27.2727272727273	0.00024965907059904	0.00740655242777151	0.494824277927297	0.511052117516234	0.271878727882354	0.4940753007155	0.0607455099595021
down	LTA; TNF; PSMB10; NOTCH2; BLNK;	GO:0006959~humoral immune response	5	58	8.62068965517241	0.00027285124822418	0.00797895007307	0.539699768987432	0.5585265051149	0.284583851897822	0.539699768987432	0.0654400810440055
down	MCM3; MCM2; POLE; CDC45;	GO:0006270~DNA replication initiation	4	31	12.9032258064516	0.00027888060503267	0.00804040279580112	0.551346956149593	0.57086859850188	0.287742884521301	0.551346956149593	0.0659440911103765
down	CDC45; MCM3; MCM2; POLE; CHAF1A; MCM9; MCM8;	GO:0006260~DNA replication	7	132	5.3030303030303	0.00029345343900044	0.00834304430047102	0.579863995464882	0.600699189633913	0.295214159634449	0.579863995464882	0.0684262327971283
down	HLA-G; HLA-B; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	3	12	25	0.00030997576928248	0.00850199613661751	0.612202144332916	0.634520399721255	0.303776253896839	0.611892168563633	0.0697298906649257
down	HLA-B; HLA-G; FCGRT;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	3	12	25	0.00030997576928248	0.00850199613661751	0.612202144332916	0.634520399721255	0.303776253896839	0.611892168563633	0.0697298906649257
down	N4BP1; TLK2; SMARCC1; USP7;	GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process	4	32	12.5	0.00031150449938754	0.00850199613661751	0.614598377291635	0.637649710246313	0.304651400401023	0.614598377291635	0.0697298906649257
down	LRP4; APC; PSMB9; PSMB10; SOX2; KREMEN1; ZNRF3; TLE3;	GO:0090090~negative regulation of canonical Wnt signaling pathway	8	179	4.46927374301676	0.00033344595407525	0.00888064511889951	0.657555421436395	0.682563867992039	0.315773318509263	0.657555421436395	0.0728354145572728
down	WIPF3; MYO1G; ARPC1B; WIPF2; ELMO2; NCKIPSD; WASF2;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	7	135	5.18518518518519	0.00033405455503432	0.00888064511889951	0.658421527972653	0.683809674155262	0.316051787678382	0.658421527972653	0.0728354145572728
down	EMP2; MARK2; GPRC5D; MAP3K3; MAP4K1; STK24;	GO:0032147~activation of protein kinase activity	6	96	6.25	0.00034695900655978	0.00910544982599855	0.683509242922783	0.710225086427887	0.321284040074364	0.683509242922783	0.0746791707052511
down	CCL22; LTA; AREG; PTGIR; ESR2; TSPAN32; PKP4; ASH1L; ADGRG1;	GO:0007267~cell-cell signaling	9	230	3.91304347826087	0.00036885252545948	0.0095574825267793	0.726270622629725	0.755041119615564	0.32938530523532	0.726270622629725	0.0783865578054002
down	HIP1R; RASSF2; HCFC1; EPHA4; EP300; USP7; PIM2; MCM8;	GO:0050821~protein stabilization	8	183	4.37158469945355	0.00038403066784076	0.00972477268753689	0.75577235431062	0.786110777070041	0.334874742357145	0.75577235431062	0.0797586031970352
down	PIK3CD; LCK; TCIRG1; PREX1;	GO:0030217~T cell differentiation	4	34	11.7647058823529	0.00038481025290204	0.00972477268753689	0.756921767458324	0.787706587690488	0.335169730277682	0.756921767458324	0.0797586031970352
down	TNF; CDH1; EMP2; PPIL2; PACS1; TSPAN33; SMURF1;	GO:0072659~protein localization to plasma membrane	7	144	4.86111111111111	0.00048351180734329	0.0118277267309594	0.950584213236919	0.989748669631726	0.369761244619291	0.897626032864534	0.09700617108167
down	CCL22; IFIT3; TNF; IFIT2; EIF2AK2; PIM2;	GO:0009615~response to virus	6	104	5.76923076923077	0.00051938325414391	0.0125079708380305	1	1	0.376583268202372	0.897626032864534	0.102585254681489
down	LRP4; APC; TLE3; MARK2; KREMEN1; CELSR2; GID8; ZNRF3;	GO:0016055~Wnt signaling pathway	8	194	4.12371134020619	0.00055605877690712	0.0132354920503358	1	1	0.383525522559256	0.897626032864534	0.108552085738018
down	PIK3C2B; TNF; AXL; SMPD3;	GO:0043491~protein kinase B signaling	4	38	10.5263157894737	0.00056707398620692	0.0133425339053514	1	1	0.385610310620708	0.897626032864534	0.109429999198207
down	PIP4K2A; DAPK1; EP300; MTMR8; HDAC6;	GO:0010506~regulation of autophagy	5	70	7.14285714285714	0.00061301297608373	0.0142595177504933	1	1	0.394167343621843	0.897626032864534	0.116950725182527
down	EPB41; MKI67; RASSF2; HCFC1; CHAF1A; CAMK1; STOX1; TLK2; RBM38;	GO:0007049~cell cycle	9	248	3.62903225806452	0.00062177077800029	0.0143007278940068	1	1	0.395767459609449	0.897626032864534	0.117288713903683
down	WASF2; DBNL; HCLS1;	GO:0098974~postsynaptic actin cytoskeleton organization	3	16	18.75	0.00064259142365608	0.0144650285186995	1	1	0.399691865514082	0.897626032864534	0.118636240344756
down	PSMB9; PSMB10; EP300; STOX1; CREBBP;	GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia	5	71	7.04225352112676	0.00065134819817691	0.0144650285186995	1	1	0.40123049007698	0.897626032864534	0.118636240344756
down	NOTCH2; EP300; MAML1; CREBBP; MAML3; SPEN;	GO:0007219~Notch signaling pathway	6	109	5.5045871559633	0.00065694099993041	0.0144650285186995	1	1	0.402312975778725	0.897626032864534	0.118636240344756
down	CDH1; CD200; NECTIN1; ELMO2; SIGLEC1; CELSR2; PKP4;	GO:0098609~cell-cell adhesion	7	152	4.60526315789474	0.00065718009391257	0.0144650285186995	1	1	0.402312975778725	0.897626032864534	0.118636240344756
down	PIP4K2A; EP300; WASF2;	GO:0035855~megakaryocyte development	3	17	17.6470588235294	0.00075091888188905	0.0161803258023883	1	1	0.41976365497598	0.897626032864534	0.132704406235155
down	SREBF1; FZD5; HDAC6;	GO:1903146~regulation of autophagy of mitochondrion	3	17	17.6470588235294	0.00075091888188905	0.0161803258023883	1	1	0.41976365497598	0.897626032864534	0.132704406235155
down	HCLS1; NCOA6; RBM14; GHRL;	GO:0009725~response to hormone	4	42	9.52380952380952	0.00080348931773821	0.0166256020203462	1	1	0.429821071748745	0.897626032864534	0.136356379430035
down	HLA-B; CYBA; HLA-G; PSMB9; PSMB10;	GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	5	75	6.66666666666667	0.00082286372189077	0.0168440203871042	1	1	0.433356048787426	0.897626032864534	0.138147757429802
down	ATP2A3; ORAI1; ORAI2; P2RX7; CACNA1I; TRPV2;	GO:0070588~calcium ion transmembrane transport	6	115	5.21739130434783	0.00085748198148205	0.0171631935434797	1	1	0.439888256500295	0.897626032864534	0.140765484953976
down	ARID1A; ESR2; PADI2;	GO:0030520~intracellular estrogen receptor signaling pathway	3	18	16.6666666666667	0.00087019818818157	0.0171631935434797	1	1	0.442060679596238	0.897626032864534	0.140765484953976
down	PIK3CD; PREX1; GBF1; CXCL2; CCL22;	GO:0030593~neutrophil chemotaxis	5	76	6.57894736842105	0.0008705452698019	0.0171631935434797	1	1	0.442236997059367	0.897626032864534	0.140765484953976
down	CDH1; EPHA4; NECTIN1; NECTIN4;	GO:0034332~adherens junction organization	4	43	9.30232558139535	0.00087199420054806	0.0171631935434797	1	1	0.442457788732816	0.897626032864534	0.140765484953976
down	IFIT2; CAMK1; TMC8; PIM2; TFIP11;	GO:0032091~negative regulation of protein binding	5	77	6.49350649350649	0.00092025301947784	0.0179405517225824	1	1	0.451565831822212	0.897626032864534	0.14714105840347
down	MECP2; CCDC134; CELSR2;	GO:0021591~ventricular system development	3	19	15.7894736842105	0.00100084529430167	0.0183053252916893	1	1	0.466393907144577	0.897626032864534	0.150132781839068
down	WASF2; WIPF2; WIPF3;	GO:0030048~actin filament-based movement	3	19	15.7894736842105	0.00100084529430167	0.0183053252916893	1	1	0.466393907144577	0.897626032864534	0.150132781839068
down	LRP4; KREMEN1; SMURF1;	GO:0030279~negative regulation of ossification	3	19	15.7894736842105	0.00100084529430167	0.0183053252916893	1	1	0.466393907144577	0.897626032864534	0.150132781839068
down	PTPN23; UBAP1; HDAC6;	GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	3	19	15.7894736842105	0.00100084529430167	0.0183053252916893	1	1	0.466393907144577	0.897626032864534	0.150132781839068
down	CD74; IL1RL2; ZMIZ1;	GO:0045582~positive regulation of T cell differentiation	3	19	15.7894736842105	0.00100084529430167	0.0183053252916893	1	1	0.466393907144577	0.897626032864534	0.150132781839068
down	ADGRB1; FLT3LG; NFATC2;	GO:1901741~positive regulation of myoblast fusion	3	19	15.7894736842105	0.00100084529430167	0.0183053252916893	1	1	0.466393907144577	0.897626032864534	0.150132781839068
down	NCOR1; FOS; IRF1; POLR2A; RUNX3; ZFHX3; RREB1; ASH1L; CTDP1;	GO:0006366~transcription by RNA polymerase II	9	266	3.38345864661654	0.00100156152060049	0.0183053252916893	1	1	0.466727668599829	0.897626032864534	0.150132781839068
down	ADGRB1; ERBB2; KLRD1; ADGRG5; CD101; P2RX7; DOK1; ADGRG1; CABIN1;	GO:0007166~cell surface receptor signaling pathway	9	268	3.35820895522388	0.0010533701195693	0.0190818463252951	1	1	0.474016553806184	0.897626032864534	0.156501489364015
down	MECP2; SCARF1; IGSF9; GHRL;	GO:0016358~dendrite development	4	46	8.69565217391304	0.0011020873085581	0.0196171540923341	1	1	0.479407979222772	0.897626032864534	0.160891864455689
down	LTA; TNF; IL12RB1; FZD5;	GO:0032729~positive regulation of interferon-gamma production	4	46	8.69565217391304	0.0011020873085581	0.0196171540923341	1	1	0.479407979222772	0.897626032864534	0.160891864455689
down	TNF; ERBB2; ZFHX3; ADGRG1;	GO:0045785~positive regulation of cell adhesion	4	48	8.33333333333333	0.00127722491389992	0.0210845112802673	1	1	0.498867428737932	0.897626032864534	0.172926527214508
down	TIAM1; DBNL; WASF2;	GO:0016601~Rac protein signal transduction	3	21	14.2857142857143	0.00129783700087771	0.0212533787263734	1	1	0.500965082338796	0.897626032864534	0.174311508854658
down	RGS19; RUFY1; RAPGEFL1; TIAM1; ARHGAP32;	GO:0007264~small GTPase mediated signal transduction	5	85	5.88235294117647	0.00139732912257684	0.022701053285038	1	1	0.511109557088871	0.897626032864534	0.186184742748439
down	CD74; EPB41; IL2RB; APC; KNTC1; CREBBP;	GO:0065003~protein-containing complex assembly	6	128	4.6875	0.00145162478474803	0.0233974483021985	1	1	0.516265769518519	0.897626032864534	0.191896289498861
down	TIAM1; HCLS1; DBNL;	GO:0061003~positive regulation of dendritic spine morphogenesis	3	22	13.6363636363636	0.00146494459356705	0.0234276686174356	1	1	0.517344976771236	0.897626032864534	0.192144144148931
down	WWP2; ITGB7; AXL; NECTIN1; NECTIN4;	GO:0046718~viral entry into host cell	5	87	5.74712643678161	0.00154067151664794	0.024447710035491	1	1	0.524789304351202	0.897626032864534	0.20051010614324
down	IRF1; EP300; CREBBP; ZBP1;	GO:0032481~positive regulation of type I interferon production	4	51	7.84313725490196	0.00157505685266079	0.0246117662396691	1	1	0.527867247485227	0.897626032864534	0.201855627947345
down	N4BP1; EP300; CREBBP; INO80;	GO:0034644~cellular response to UV	4	51	7.84313725490196	0.00157505685266079	0.0246117662396691	1	1	0.527867247485227	0.897626032864534	0.201855627947345
down	FOS; CTCF; KMT2E;	GO:0006306~DNA methylation	3	23	13.0434782608696	0.00164494649522129	0.0251110783274944	1	1	0.534607610946919	0.897626032864534	0.205950781218679
down	FOS; TNF; NOTCH2;	GO:0045672~positive regulation of osteoclast differentiation	3	23	13.0434782608696	0.00164494649522129	0.0251110783274944	1	1	0.534607610946919	0.897626032864534	0.205950781218679
down	ADGRB1; HGS; HLA-G; MECP2; GHRL;	GO:0016525~negative regulation of angiogenesis	5	89	5.61797752808989	0.00169453694832233	0.0253191031621593	1	1	0.539364676322189	0.897626032864534	0.207656915724468
down	GBF1; PIM2; MAP4K1; STK24; MAP3K3;	GO:0007346~regulation of mitotic cell cycle	5	90	5.55555555555556	0.0017755573896685	0.0262964122856929	1	1	0.546985175965577	0.897626032864534	0.215672404938387
down	LCK; CSF1R; NOTCH2; RUNX3;	GO:0030097~hemopoiesis	4	53	7.54716981132075	0.00179848447483977	0.0262964122856929	1	1	0.5494128494234	0.897626032864534	0.215672404938387
down	TNF; CYBA; P2RX7; IL1RL2;	GO:0032755~positive regulation of interleukin-6 production	4	53	7.54716981132075	0.00179848447483977	0.0262964122856929	1	1	0.5494128494234	0.897626032864534	0.215672404938387
down	USP43; USP7; SMURF1; ZNRF3; FBXO7; RNF144A; WWP2; RNF166; HUWE1;	GO:0006511~ubiquitin-dependent protein catabolic process	9	291	3.09278350515464	0.00182061373498721	0.0264311795426866	1	1	0.551645961701124	0.897626032864534	0.216777710791787
down	TNF; HLA-DRB1; CD74; S100A4; AKAP13; MAP3K3; PIM2;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	7	183	3.82513661202186	0.00184187784245382	0.0265515770669223	1	1	0.553616869313775	0.897626032864534	0.217765161981646
down	PHLPP1; LCK; PPP2R2A; PTPN13; CTDP1; PTPRF;	GO:0006470~protein dephosphorylation	6	137	4.37956204379562	0.00201793458594546	0.028886098583429	1	1	0.564779676417992	0.897626032864534	0.236911951451453
down	RAF1; ERBB2; CRIP1; EP300; AKAP13; NCOA6; ADAP2;	GO:0007507~heart development	7	190	3.68421052631579	0.00225779921788871	0.0306073840994582	1	1	0.575295208646492	0.897626032864534	0.25102923037127
down	CSF1R; PLCB2; PIK3C2B; PIK3CD;	GO:0048015~phosphatidylinositol-mediated signaling	4	57	7.01754385964912	0.00230947843046292	0.0310730156615949	1	1	0.57736960761573	0.897626032864534	0.254848149763398
down	COL5A3; ITGB7; EMP2; TIAM1; SIGLEC1;	GO:0007160~cell-matrix adhesion	5	96	5.20833333333333	0.00232250678858037	0.0310730156615949	1	1	0.578200573258308	0.897626032864534	0.254848149763398
down	CD74; CSF1R; MKI67; EMP2; MAP4K1; YY1AP1;	GO:0008283~cell population proliferation	6	142	4.22535211267606	0.00239709339922878	0.0318626635598786	1	1	0.580823703033961	0.897626032864534	0.261324518456859
down	PTPRF; PTPN13; MTMR1; MTMR8; PTPN23;	GO:0035335~peptidyl-tyrosine dephosphorylation	5	99	5.05050505050505	0.00263767252498637	0.0348342945719167	1	1	0.589104859567672	0.897626032864534	0.285696619106667
down	ACAP1; COG1; GBF1; PTPN23; UBAP1; MYO5B; AGAP1; EXOC7; RUFY1;	GO:0015031~protein transport	9	310	2.90322580645161	0.00274574693177387	0.0357069479218141	1	1	0.591734791976456	0.897626032864534	0.292853764522747
down	POLQ; LIG1; SMPD3;	GO:0071897~DNA biosynthetic process	3	28	10.7142857142857	0.00275013302274874	0.0357069479218141	1	1	0.591734791976456	0.897626032864534	0.292853764522747
down	RAF1; LCK; DGKA; ENTPD2; AXL;	GO:0030168~platelet activation	5	102	4.90196078431373	0.00298271250628845	0.0362967535789076	1	1	0.597306682673033	0.897626032864534	0.297691108991248
down	DIAPH1; HCLS1; PREX1;	GO:0030041~actin filament polymerization	3	29	10.3448275862069	0.00301438598359272	0.0362967535789076	1	1	0.598121770683503	0.897626032864534	0.297691108991248
down	TNF; EPB41; CIT;	GO:0030866~cortical actin cytoskeleton organization	3	29	10.3448275862069	0.00301438598359272	0.0362967535789076	1	1	0.598121770683503	0.897626032864534	0.297691108991248
down	ITGAX; ITGB7; CD200;	GO:0034113~heterotypic cell-cell adhesion	3	29	10.3448275862069	0.00301438598359272	0.0362967535789076	1	1	0.598121770683503	0.897626032864534	0.297691108991248
down	APC; CDKN2D; FBXO7;	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	3	29	10.3448275862069	0.00301438598359272	0.0362967535789076	1	1	0.598121770683503	0.897626032864534	0.297691108991248
down	TLE3; EP300; CREBBP;	GO:1904837~beta-catenin-TCF complex assembly	3	29	10.3448275862069	0.00301438598359272	0.0362967535789076	1	1	0.598121770683503	0.897626032864534	0.297691108991248
down	DIAPH1; RAF1; ERBB2;	GO:2000145~regulation of cell motility	3	29	10.3448275862069	0.00301438598359272	0.0362967535789076	1	1	0.598121770683503	0.897626032864534	0.297691108991248
down	MECP2; MPP2; P2RX7; GHRL;	GO:0060079~excitatory postsynaptic potential	4	62	6.45161290322581	0.00307846958734648	0.0368516213175336	1	1	0.599809145863074	0.897626032864534	0.302241906959886
down	POLR2A; PPP1R13L; EPC1; INO80; PLAGL2;	GO:0006351~transcription, DNA-templated	5	103	4.85436893203883	0.00310463480558432	0.036948764226925	1	1	0.600243396828405	0.897626032864534	0.303038633321776
down	MECP2; FZD5; DBNL; CDH1;	GO:0007416~synapse assembly	4	63	6.34920634920635	0.00325082036019719	0.0384238471964453	1	1	0.603910404980087	0.897626032864534	0.315136659777393
down	REC8; CNTD1; RAD54L;	GO:0007131~reciprocal meiotic recombination	3	30	10	0.0032937155270063	0.0384238471964453	1	1	0.604884454020377	0.897626032864534	0.315136659777393
down	ERBB2; EPHA4; RNF165;	GO:0008045~motor neuron axon guidance	3	30	10	0.0032937155270063	0.0384238471964453	1	1	0.604884454020377	0.897626032864534	0.315136659777393
down	KPNA7; WWP2; PIK3CD; TNF; MECP2; NOTCH2; STOX1;	GO:0010629~negative regulation of gene expression	7	204	3.43137254901961	0.00330366248489222	0.0384238471964453	1	1	0.604884454020377	0.897626032864534	0.315136659777393
down	CYBA; AXL; ELMO2; WASF2;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	4	64	6.25	0.00342962601917673	0.0384352084596886	1	1	0.607958400991684	0.897626032864534	0.31522984020597
down	SMC4; INO80; KIF18B;	GO:0000070~mitotic sister chromatid segregation	3	31	9.67741935483871	0.00358838648741244	0.0388646938610226	1	1	0.611861825717152	0.897626032864534	0.318752303589388
down	DIAPH1; TJP1; MARK2;	GO:0051493~regulation of cytoskeleton organization	3	31	9.67741935483871	0.00358838648741244	0.0388646938610226	1	1	0.611861825717152	0.897626032864534	0.318752303589388
down	NCOA2; ZFHX3; HUWE1; KDM2A;	GO:0032922~circadian regulation of gene expression	4	65	6.15384615384615	0.00361500049930874	0.0389468738004473	1	1	0.612450013004551	0.897626032864534	0.31942630979909
down	ANO9; RAF1; TCIRG1; ATP13A5; TMC8; ATP2A3; FXYD6;	GO:0034220~ion transmembrane transport	7	208	3.36538461538462	0.00366125222053237	0.0392386559970145	1	1	0.613650895382991	0.897626032864534	0.321819387887772
down	MARK2; CDC42BPG; CIT; CDC42BPB;	GO:0018107~peptidyl-threonine phosphorylation	4	66	6.06060606060606	0.00380705662687153	0.0403784710632436	1	1	0.616804291556594	0.897626032864534	0.331167684295963
down	GAS8; INPP5B; ASH1L; CACNA1I;	GO:0030317~flagellated sperm motility	4	66	6.06060606060606	0.00380705662687153	0.0403784710632436	1	1	0.616804291556594	0.897626032864534	0.331167684295963
down	TNF; CSF1R; TCIRG1;	GO:0030316~osteoclast differentiation	3	32	9.375	0.00389865266386025	0.0409258564252406	1	1	0.619495189624734	0.897626032864534	0.335657114875593
down	LRP4; KREMEN1; ZNRF3;	GO:0060173~limb development	3	32	9.375	0.00389865266386025	0.0409258564252406	1	1	0.619495189624734	0.897626032864534	0.335657114875593
down	MECP2; PPP1R13L; ASH1L; PLAGL2;	GO:0009791~post-embryonic development	4	67	5.97014925373134	0.0040059060828681	0.0416248210742691	1	1	0.621620387530822	0.897626032864534	0.341389736694308
down	CHN2; ARHGAP4; LDLRAP1; BLNK;	GO:0009967~positive regulation of signal transduction	4	67	5.97014925373134	0.0040059060828681	0.0416248210742691	1	1	0.621620387530822	0.897626032864534	0.341389736694308
down	DIAPH1; CSF1R; EPB41; FGD2; WIPF2; WIPF3;	GO:0008360~regulation of cell shape	6	159	3.77358490566038	0.00409422858984987	0.0423277066839529	1	1	0.623844431851147	0.897626032864534	0.347154516626648
down	ITGAX; NOTCH2; TLE3; EP300; SMARCC1;	GO:0009887~animal organ morphogenesis	5	111	4.5045045045045	0.00421270035102217	0.0428041541450668	1	1	0.626975886254165	0.897626032864534	0.351062143592975
down	EP300; CAMK1; SCARF1; MARK2; NCKIPSD;	GO:0010976~positive regulation of neuron projection development	5	111	4.5045045045045	0.00421270035102217	0.0428041541450668	1	1	0.626975886254165	0.897626032864534	0.351062143592975
down	PIK3CD; ERBB2; PIK3C2B;	GO:0014065~phosphatidylinositol 3-kinase signaling	3	33	9.09090909090909	0.00422475704246428	0.0428041541450668	1	1	0.626975886254165	0.897626032864534	0.351062143592975
down	ERN1; TNF; LDLRAP1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	3	33	9.09090909090909	0.00422475704246428	0.0428041541450668	1	1	0.626975886254165	0.897626032864534	0.351062143592975
down	RAF1; PSMB9; PSMB10; EP300; CREBBP;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	5	112	4.46428571428571	0.00436865817846299	0.0436226502015305	1	1	0.630008864343189	0.897626032864534	0.357775113066234
down	POLQ; LIG1; HUWE1;	GO:0006284~base-excision repair	3	34	8.82352941176471	0.0045669320149333	0.0447297121271218	1	1	0.63464832178955	0.897626032864534	0.366854781627634
down	NOTCH2; CRB2; RNF165;	GO:0030513~positive regulation of BMP signaling pathway	3	34	8.82352941176471	0.0045669320149333	0.0447297121271218	1	1	0.63464832178955	0.897626032864534	0.366854781627634
down	SMARCC1; INO80; ARID1A;	GO:0043044~ATP-dependent chromatin remodeling	3	34	8.82352941176471	0.0045669320149333	0.0447297121271218	1	1	0.63464832178955	0.897626032864534	0.366854781627634
down	LRP4; CELSR2; RERE;	GO:0048813~dendrite morphogenesis	3	34	8.82352941176471	0.0045669320149333	0.0447297121271218	1	1	0.63464832178955	0.897626032864534	0.366854781627634
down	LTA; RAF1; CYBA; MECP2; EP300; CREBBP;	GO:0001666~response to hypoxia	6	163	3.68098159509202	0.00459741930336455	0.0448138919713678	1	1	0.63464832178955	0.897626032864534	0.367545190237699
down	HIP1R; EPB41; EP300; TIAM1;	GO:0032092~positive regulation of protein binding	4	70	5.71428571428571	0.00464431334898197	0.0450564427742468	1	1	0.636270928810529	0.897626032864534	0.369534492596071
down	ERN1; HDAC6; EXOC7; PRKAB1;	GO:0016241~regulation of macroautophagy	4	71	5.63380281690141	0.00487142886302228	0.0460428715130376	1	1	0.640694942004928	0.897626032864534	0.37762477715976
down	EPHA4; FGD2; ARHGAP9; CHN2;	GO:0043087~regulation of GTPase activity	4	71	5.63380281690141	0.00487142886302228	0.0460428715130376	1	1	0.640694942004928	0.897626032864534	0.37762477715976
down	HGS; AREG; ARHGEF7;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	3	35	8.57142857142857	0.00492539959460525	0.0460428715130376	1	1	0.64162156692105	0.897626032864534	0.37762477715976
down	FOS; TNF; SREBF1;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	3	35	8.57142857142857	0.00492539959460525	0.0460428715130376	1	1	0.64162156692105	0.897626032864534	0.37762477715976
down	CD74; ADORA3; CDH1; STK24; ARHGAP4;	GO:0030336~negative regulation of cell migration	5	116	4.31034482758621	0.00503374342715157	0.0460428715130376	1	1	0.644319158675401	0.897626032864534	0.37762477715976
down	PIK3C2B; SREBF1; KIAA1324; STK24;	GO:0009267~cellular response to starvation	4	72	5.55555555555556	0.00510587778869542	0.0460428715130376	1	1	0.645502901475376	0.897626032864534	0.37762477715976
down	EP300; TCIRG1; GON4L; BLNK;	GO:0030183~B cell differentiation	4	72	5.55555555555556	0.00510587778869542	0.0460428715130376	1	1	0.645502901475376	0.897626032864534	0.37762477715976
down	TNF; RAF1; CDKN2D; MICAL1;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	4	72	5.55555555555556	0.00510587778869542	0.0460428715130376	1	1	0.645502901475376	0.897626032864534	0.37762477715976
down	HLA-B; HLA-DRB1; IRF1; HLA-G;	GO:0060333~interferon-gamma-mediated signaling pathway	4	72	5.55555555555556	0.00510587778869542	0.0460428715130376	1	1	0.645502901475376	0.897626032864534	0.37762477715976
down	TRPV2; HCLS1; DBNL;	GO:0045773~positive regulation of axon extension	3	36	8.33333333333333	0.00530037162759467	0.0475871084284486	1	1	0.64968865442612	0.897626032864534	0.390289975960379
down	LIG1; POLR2A; EP300; USP7;	GO:0006283~transcription-coupled nucleotide-excision repair	4	73	5.47945205479452	0.00534776426820405	0.0478029408603218	1	1	0.650786896536958	0.897626032864534	0.392060145181186
down	EPB41; LIG1; MAP4; KNTC1; STOX1; KIF18B; SMC4; INO80; CTDP1;	GO:0051301~cell division	9	347	2.59365994236311	0.00558583094283283	0.0495993513284671	1	1	0.655406306652651	0.897626032864534	0.406793568193883
down	TNF; APC; WWP2; SMURF1;	GO:0045732~positive regulation of protein catabolic process	4	74	5.40540540540541	0.00559719108787293	0.0495993513284671	1	1	0.655406306652651	0.897626032864534	0.406793568193883
down	GNAO1; PLCB2; FZD5;	GO:0007223~Wnt signaling pathway, calcium modulating pathway	3	37	8.10810810810811	0.00569205000199313	0.0500069800604289	1	1	0.657861887819414	0.897626032864534	0.410136772125623
down	EP300; EPC1; HCFC1;	GO:0043967~histone H4 acetylation	3	37	8.10810810810811	0.00569205000199313	0.0500069800604289	1	1	0.657861887819414	0.897626032864534	0.410136772125623
down	XRCC2; POLQ; CHAF1A; RAD54L; INO80; DOT1L; LIG1;	GO:0006281~DNA repair	7	228	3.07017543859649	0.00590812064946888	0.0505625179216344	1	1	0.661745442816848	0.897626032864534	0.414693066165236
down	ARHGAP25; EMP2; MYO1G; MYO5B; HIP1R;	GO:0007015~actin filament organization	5	121	4.13223140495868	0.00596215029700331	0.0505625179216344	1	1	0.663096863054051	0.897626032864534	0.414693066165236
down	ERN1; MAP4K1; DBNL;	GO:0007257~activation of JUN kinase activity	3	38	7.89473684210526	0.00610062685335122	0.0509713598726937	1	1	0.665890810510739	0.897626032864534	0.418046220423189
down	SON; CLK3; RBM38;	GO:0043484~regulation of RNA splicing	3	38	7.89473684210526	0.00610062685335122	0.0509713598726937	1	1	0.665890810510739	0.897626032864534	0.418046220423189
down	ARHGEF7; PREX1; RREB1;	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	3	38	7.89473684210526	0.00610062685335122	0.0509713598726937	1	1	0.665890810510739	0.897626032864534	0.418046220423189
down	CCL22; SERPIND1; CXCL2; C3AR1; CMTM7;	GO:0006935~chemotaxis	5	122	4.0983606557377	0.00616132947309977	0.0512692741115254	1	1	0.667335408343459	0.897626032864534	0.420489591011396
down	PIK3CD; HLA-DRB1; LCK; PSMB9; PSMB10; THEMIS2;	GO:0050852~T cell receptor signaling pathway	6	174	3.44827586206897	0.00621521012916071	0.0515082394104938	1	1	0.668813215321758	0.897626032864534	0.422449486534991
down	CSF1R; EPHA4; GHRL;	GO:0061098~positive regulation of protein tyrosine kinase activity	3	39	7.69230769230769	0.00652628476627015	0.0536313767074193	1	1	0.675080541302016	0.897626032864534	0.439862589199625
down	HLA-G; CBX5; EPC1;	GO:0070317~negative regulation of G0 to G1 transition	3	39	7.69230769230769	0.00652628476627015	0.0536313767074193	1	1	0.675080541302016	0.897626032864534	0.439862589199625
down	FOS; NOTCH2; EP300; ARHGEF7; SMARCC1; RAPGEFL1; NAV2; AXL;	GO:0007399~nervous system development	8	294	2.72108843537415	0.00669157553682442	0.0536313767074193	1	1	0.678446327476598	0.897626032864534	0.439862589199625
down	ADORA3; CD200; NWD1; USP7;	GO:0032088~negative regulation of NF-kappaB transcription factor activity	4	79	5.06329113924051	0.00696092986547825	0.0536313767074193	1	1	0.68381864002449	0.897626032864534	0.439862589199625
down	IRF1; CYBA; CASP2; KCNJ2;	GO:0071260~cellular response to mechanical stimulus	4	79	5.06329113924051	0.00696092986547825	0.0536313767074193	1	1	0.68381864002449	0.897626032864534	0.439862589199625
down	MECP2; EP300; CREBBP;	GO:0016573~histone acetylation	3	40	7.5	0.00696919697321619	0.0536313767074193	1	1	0.68381864002449	0.897626032864534	0.439862589199625
down	SREBF1; USP7; HDAC6; FBXO7;	GO:0031647~regulation of protein stability	4	80	5	0.0072576783261562	0.0556422005005309	1	1	0.689620737576213	0.897626032864534	0.456354542499416
down	CD74; NFATC2; TNFSF13B;	GO:0030890~positive regulation of B cell proliferation	3	41	7.31707317073171	0.00742952755043946	0.0567471749841402	1	1	0.693753738571961	0.897626032864534	0.465417090716507
down	FOS; SREBF1; NCOA2;	GO:0032570~response to progesterone	3	42	7.14285714285714	0.00790743161058272	0.0589703434521612	1	1	0.701353755255431	0.897626032864534	0.483650608082758
down	TJP1; PKP4; CDH1;	GO:0007043~cell-cell junction assembly	3	43	6.97674418604651	0.00840305549140896	0.0620976700033002	1	1	0.705856661278353	0.897626032864534	0.509299659785479
down	SMURF1; SMPD3; RGMA; ZCCHC18;	GO:0030509~BMP signaling pathway	4	85	4.70588235294118	0.00886651933771154	0.0635399205200201	1	1	0.710233055844201	0.897626032864534	0.521128407908425
down	RAF1; EIF2AK2; MAP3K3;	GO:0000186~activation of MAPKK activity	3	44	6.81818181818182	0.00891653694305972	0.0635399205200201	1	1	0.711485671462974	0.897626032864534	0.521128407908425
down	FOS; AREG; SREBF1;	GO:0051591~response to cAMP	3	44	6.81818181818182	0.00891653694305972	0.0635399205200201	1	1	0.711485671462974	0.897626032864534	0.521128407908425
down	CIT; XRCC2; CLIP1; KIF18B; POLE;	GO:0000278~mitotic cell cycle	5	134	3.73134328358209	0.00892781147100163	0.0635399205200201	1	1	0.711485671462974	0.897626032864534	0.521128407908425
down	HGS; SYNJ2; HIP1R; AREG; LDLRAP1;	GO:0061024~membrane organization	5	134	3.73134328358209	0.00892781147100163	0.0635399205200201	1	1	0.711485671462974	0.897626032864534	0.521128407908425
down	FOS; RLN1; SLC19A1; CLIC5;	GO:0007565~female pregnancy	4	86	4.65116279069767	0.0092139235340376	0.0643716773862627	1	1	0.714101427608058	0.897626032864534	0.527950137113065
down	ARPC1B; EPHA4; TIAM1; ARHGEF7;	GO:0048013~ephrin receptor signaling pathway	4	86	4.65116279069767	0.0092139235340376	0.0643716773862627	1	1	0.714101427608058	0.897626032864534	0.527950137113065
down	TNF; CASP2; CRIP1;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	3	45	6.66666666666667	0.00944800531089152	0.0653380637547126	1	1	0.716875714428602	0.897626032864534	0.535876042362758
down	TNF; CYBA; IL2RB;	GO:0050766~positive regulation of phagocytosis	3	45	6.66666666666667	0.00944800531089152	0.0653380637547126	1	1	0.716875714428602	0.897626032864534	0.535876042362758
down	TNF; CYBA; HCFC1;	GO:0071407~cellular response to organic cyclic compound	3	45	6.66666666666667	0.00944800531089152	0.0653380637547126	1	1	0.716875714428602	0.897626032864534	0.535876042362758
down	HIP1R; TNF; LCK; ATP2A3;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	4	87	4.59770114942529	0.00957007113760489	0.0655181793266796	1	1	0.717755335320366	0.897626032864534	0.537353276525006
down	GNAO1; PDE1B; NAV2; MECP2;	GO:0007626~locomotory behavior	4	87	4.59770114942529	0.00957007113760489	0.0655181793266796	1	1	0.717755335320366	0.897626032864534	0.537353276525006
down	PIK3CD; TNF; HCLS1; PRR5L;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	4	87	4.59770114942529	0.00957007113760489	0.0655181793266796	1	1	0.717755335320366	0.897626032864534	0.537353276525006
down	LTA; LCK; AOC1; NFATC2; RAD54L; NPC1L1;	GO:0042493~response to drug	6	193	3.10880829015544	0.00992771039154716	0.0669798064315025	1	1	0.72136741689996	0.897626032864534	0.549340943488677
down	APC; SREBF1; TCIRG1; SMARCC1;	GO:0008286~insulin receptor signaling pathway	4	88	4.54545454545455	0.00993504384776833	0.0669798064315025	1	1	0.72136741689996	0.897626032864534	0.549340943488677
down	XRCC2; EP300; CRB2;	GO:0001756~somitogenesis	3	46	6.52173913043478	0.00999758171535858	0.0669798064315025	1	1	0.72136741689996	0.897626032864534	0.549340943488677
down	FOS; LTA; PTGIR; OTUD5; P2RX7;	GO:0032496~response to lipopolysaccharide	5	138	3.6231884057971	0.0100138669466658	0.0669798064315025	1	1	0.72136741689996	0.897626032864534	0.549340943488677
down	CHD2; NCOR1; SOX2; TLK2; PADI2;	GO:0006325~chromatin organization	5	139	3.59712230215827	0.0102989029893504	0.0675700462153857	1	1	0.724607333436676	0.897626032864534	0.554181848487328
down	NECTIN1; NECTIN4; CRB2;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	3	47	6.38297872340426	0.0105653792306474	0.0690969050643297	1	1	0.728066905331814	0.897626032864534	0.566704519503266
down	IRF1; EIF2AK2; IFNLR1; SAMHD1; IFIT3; IFIT2;	GO:0051607~defense response to virus	6	198	3.03030303030303	0.0111212784370429	0.0723452259683827	1	1	0.733719598696192	0.897626032864534	0.593345917340261
down	NCOR1; NCOA6; NCOA2; CREBBP;	GO:0019216~regulation of lipid metabolic process	4	92	4.34782608695652	0.0114847629826647	0.0723982269312842	1	1	0.735740864808302	0.897626032864534	0.593780609533584
down	LRP4; CD74; HCLS1; AREG;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	4	92	4.34782608695652	0.0114847629826647	0.0723982269312842	1	1	0.735740864808302	0.897626032864534	0.593780609533584
down	DIAPH1; TFAP2A; CDKN2D; NAV2; CLIC5;	GO:0007605~sensory perception of sound	5	143	3.4965034965035	0.0114945890340339	0.0723982269312842	1	1	0.735740864808302	0.897626032864534	0.593780609533584
down	MAP3K3; STK24; MAP4K1;	GO:0023014~signal transduction by protein phosphorylation	3	49	6.12244897959184	0.0117560507000907	0.0735921583580599	1	1	0.740012219611253	0.897626032864534	0.603572746169818
down	EP300; CREBBP; HDAC6;	GO:0031648~protein destabilization	3	49	6.12244897959184	0.0117560507000907	0.0735921583580599	1	1	0.740012219611253	0.897626032864534	0.603572746169818
down	PHLPP1; RAF1; CASP2; DAPK1; CREBBP; PPP1R13B;	GO:0042981~regulation of apoptotic process	6	202	2.97029702970297	0.0121465186259289	0.0756754941839238	1	1	0.742271109170506	0.897626032864534	0.620659413467882
down	SFI1; RIMBP2; FKBP15;	GO:0010923~negative regulation of phosphatase activity	3	50	6	0.0123791121246752	0.0756754941839238	1	1	0.744618582634044	0.897626032864534	0.620659413467882
down	MAP4K1; STK24; MAP3K3;	GO:0031098~stress-activated protein kinase signaling cascade	3	50	6	0.0123791121246752	0.0756754941839238	1	1	0.744618582634044	0.897626032864534	0.620659413467882
down	LCK; P2RX7; PLCB2;	GO:0051209~release of sequestered calcium ion into cytosol	3	50	6	0.0123791121246752	0.0756754941839238	1	1	0.744618582634044	0.897626032864534	0.620659413467882
down	LTA; TNF; LYZ; P2RX7;	GO:0050830~defense response to Gram-positive bacterium	4	95	4.21052631578947	0.0127434769603134	0.0758310969120976	1	1	0.749600975291347	0.897626032864534	0.621935603323578
down	PSMB9; PSMB10; MAP3K3; IL1RL2;	GO:0070498~interleukin-1-mediated signaling pathway	4	95	4.21052631578947	0.0127434769603134	0.0758310969120976	1	1	0.749600975291347	0.897626032864534	0.621935603323578
down	CIT; SON; APC;	GO:0000281~mitotic cytokinesis	3	51	5.88235294117647	0.013020769936501	0.0770332834104555	1	1	0.75224787139054	0.897626032864534	0.6317954446764
down	ARID1A; NOTCH2; MED15;	GO:0019827~stem cell population maintenance	3	51	5.88235294117647	0.013020769936501	0.0770332834104555	1	1	0.75224787139054	0.897626032864534	0.6317954446764
down	PIK3CD; CSF1R; NECTIN1; DOK1; EPHA4; IGSF9;	GO:0007411~axon guidance	6	206	2.9126213592233	0.0132364701172316	0.0780837300575594	1	1	0.754478796682202	0.897626032864534	0.640410777908136
down	APC; GHRL; PRKAB1; TRPV2;	GO:0120162~positive regulation of cold-induced thermogenesis	4	97	4.12371134020619	0.0136296017312951	0.0783882840855468	1	1	0.757886910906211	0.897626032864534	0.642908605327942
down	TNF; TFAP2A; CASP2;	GO:0043525~positive regulation of neuron apoptotic process	3	52	5.76923076923077	0.0136810995374399	0.0783882840855468	1	1	0.757886910906211	0.897626032864534	0.642908605327942
down	TNF; HLA-DRB1; CD74; CSF1R; NOTCH2; CCL22;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	6	209	2.87081339712919	0.0140975637802827	0.0783882840855468	1	1	0.761268444135266	0.897626032864534	0.642908605327942
down	HLA-G; TCIRG1; IL1RL2;	GO:0006968~cellular defense response	3	53	5.66037735849057	0.0143601692884576	0.0783882840855468	1	1	0.764038590377853	0.897626032864534	0.642908605327942
down	LCK; TMIGD2; TNFSF13B;	GO:0031295~T cell costimulation	3	53	5.66037735849057	0.0143601692884576	0.0783882840855468	1	1	0.764038590377853	0.897626032864534	0.642908605327942
down	RALGDS; PRKAB1; GPSM3;	GO:0050790~regulation of catalytic activity	3	53	5.66037735849057	0.0143601692884576	0.0783882840855468	1	1	0.764038590377853	0.897626032864534	0.642908605327942
down	PIP4K2A; PIK3C2B; PIK3CD;	GO:0046854~phosphatidylinositol phosphorylation	3	54	5.55555555555556	0.01505804066706	0.0783882840855468	1	1	0.770776144084888	0.897626032864534	0.642908605327942
down	DIAPH1; EPB41; FGD2; NUAK2; WASF2;	GO:0030036~actin cytoskeleton organization	5	157	3.18471337579618	0.016415749336856	0.0783882840855468	1	1	0.786378900038024	0.897626032864534	0.642908605327942
down	CNOT1; CASP2; EP300;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	3	56	5.35714285714286	0.0165104007323831	0.0783882840855468	1	1	0.786378900038024	0.897626032864534	0.642908605327942
down	PTGIR; ADGRG5; ADGRB1; ADGRG1;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	4	103	3.88349514563107	0.0165191911600073	0.0783882840855468	1	1	0.786378900038024	0.897626032864534	0.642908605327942
down	MARK2; TLK2; MAP4K1; MAST2; MAST3;	GO:0018105~peptidyl-serine phosphorylation	5	158	3.16455696202532	0.0168131309683539	0.0783882840855468	1	1	0.790217155512634	0.897626032864534	0.642908605327942
down	TNF; CYBA; SMPD3;	GO:0048661~positive regulation of smooth muscle cell proliferation	3	57	5.26315789473684	0.0172649793457407	0.0783882840855468	1	1	0.794189049904071	0.897626032864534	0.642908605327942
down	FOS; RBM14; ZMIZ1;	GO:0060395~SMAD protein signal transduction	3	59	5.08474576271187	0.0188311112528724	0.0806428550933678	1	1	0.809737783873513	0.897626032864534	0.661399673465996
down	TNF; ERBB2; AKAP13;	GO:0043406~positive regulation of MAP kinase activity	3	60	5	0.0196427172464682	0.0829220795250033	1	1	0.817096825820759	0.897626032864534	0.680092938890367
down	AXL; MARK2; UNK; CELSR2;	GO:0001764~neuron migration	4	109	3.6697247706422	0.0197652882458728	0.0829220795250033	1	1	0.817096825820759	0.897626032864534	0.680092938890367
down	HLA-DRB1; CD74; SOX2; ERBB2;	GO:0043410~positive regulation of MAPK cascade	4	109	3.6697247706422	0.0197652882458728	0.0829220795250033	1	1	0.817096825820759	0.897626032864534	0.680092938890367
down	CDH1; NECTIN1; CELSR2; NECTIN4; IGSF9;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	5	165	3.03030303030303	0.0197741539898878	0.0829220795250033	1	1	0.817096825820759	0.897626032864534	0.680092938890367
down	TNF; HCLS1; EP300; ESR2;	GO:0051091~positive regulation of DNA-binding transcription factor activity	4	111	3.6036036036036	0.0209284460672911	0.0870697801773772	1	1	0.827360646104523	0.897626032864534	0.714110681118598
down	WASF2; GNAZ; GNAO1;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	3	62	4.83870967741935	0.0213230969948017	0.0870697801773772	1	1	0.831600782797267	0.897626032864534	0.714110681118598
down	ARPC1B; EP300; GHRL;	GO:0043627~response to estrogen	3	62	4.83870967741935	0.0213230969948017	0.0870697801773772	1	1	0.831600782797267	0.897626032864534	0.714110681118598
down	RAF1; POLR2A; SOX2;	GO:0035019~somatic stem cell population maintenance	3	63	4.76190476190476	0.0221918887761514	0.0870697801773772	1	1	0.836701814689574	0.897626032864534	0.714110681118598
down	SERPIND1; IRF1; CBX5; MICAL1; P2RX7;	GO:0007596~blood coagulation	5	171	2.92397660818713	0.0225684192672649	0.0870697801773772	1	1	0.836701814689574	0.897626032864534	0.714110681118598
down	FOS; IGHE; PSMB9; PSMB10; NFATC2;	GO:0038095~Fc-epsilon receptor signaling pathway	5	171	2.92397660818713	0.0225684192672649	0.0870697801773772	1	1	0.836701814689574	0.897626032864534	0.714110681118598
down	POLQ; INO80; REC8;	GO:0006302~double-strand break repair	3	64	4.6875	0.023079751358183	0.0870697801773772	1	1	0.839469753052719	0.897626032864534	0.714110681118598
down	TNF; EIF2AK2; EP300;	GO:1901224~positive regulation of NIK/NF-kappaB signaling	3	64	4.6875	0.023079751358183	0.0870697801773772	1	1	0.839469753052719	0.897626032864534	0.714110681118598
down	WWP2; CLIC5; CACNA1I; KCNJ2;	GO:0034765~regulation of ion transmembrane transport	4	115	3.47826086956522	0.0233785339960224	0.0870697801773772	1	1	0.841532332298548	0.897626032864534	0.714110681118598
down	XRCC2; RAD54L; REC8;	GO:0051321~meiotic cell cycle	3	65	4.61538461538462	0.0239866802200905	0.0870697801773772	1	1	0.841532332298548	0.897626032864534	0.714110681118598
down	CASP2; DAPK1; P2RX7;	GO:0097190~apoptotic signaling pathway	3	65	4.61538461538462	0.0239866802200905	0.0870697801773772	1	1	0.841532332298548	0.897626032864534	0.714110681118598
down	SON; MAP4; CDK5RAP2; MARK2;	GO:0000226~microtubule cytoskeleton organization	4	118	3.38983050847458	0.0253255731200663	0.0870697801773772	1	1	0.846056699676498	0.897626032864534	0.714110681118598
down	AXL; SMPD3; HDAC6;	GO:0070301~cellular response to hydrogen peroxide	3	67	4.47761194029851	0.0258576929321102	0.0870697801773772	1	1	0.84854510173437	0.897626032864534	0.714110681118598
down	EIF2AK2; PSMB9; PSMB10;	GO:1902036~regulation of hematopoietic stem cell differentiation	3	68	4.41176470588235	0.0268217423520409	0.0870697801773772	1	1	0.851205117727267	0.897626032864534	0.714110681118598
down	IRF1; SON; EP300; YY1AP1;	GO:0051726~regulation of cell cycle	4	121	3.30578512396694	0.0273674161112212	0.08836135769664	1	1	0.851205117727267	0.897626032864534	0.724703671018415
down	TNF; CSF1R; HCLS1;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	3	69	4.34782608695652	0.0278047894381873	0.0893626181956806	1	1	0.853904527852594	0.897626032864534	0.732915599605927
down	TNF; CD74; P2RX7; GHRL;	GO:0000187~activation of MAPK activity	4	122	3.27868852459016	0.0280692281053161	0.0893626181956806	1	1	0.853904527852594	0.897626032864534	0.732915599605927
down	PTPN13; PRR5L; MICAL1;	GO:0001933~negative regulation of protein phosphorylation	3	71	4.22535211267606	0.0298277553762591	0.0939344850080038	1	1	0.85798531412668	0.897626032864534	0.77041217897802
down	FOS; CDH1; SLC23A1;	GO:0009636~response to toxic substance	3	71	4.22535211267606	0.0298277553762591	0.0939344850080038	1	1	0.85798531412668	0.897626032864534	0.77041217897802
down	PIK3CD; NFATC2; LCK; IGHE;	GO:0050853~B cell receptor signaling pathway	4	125	3.2	0.030238591801719	0.0942136947003329	1	1	0.85798531412668	0.897626032864534	0.7727021425355
down	HLA-B; CD74; IL32;	GO:0006952~defense response	3	72	4.16666666666667	0.030867602314382	0.0960273281725532	1	1	0.860261137241074	0.897626032864534	0.787576821574637
down	CTCF; TLK2; CDK5RAP2;	GO:0007059~chromosome segregation	3	73	4.10958904109589	0.0319263033221413	0.0961310356389572	1	1	0.862010189697815	0.897626032864534	0.788427387744898
down	RALGDS; RREB1; DOK1;	GO:0007265~Ras protein signal transduction	3	73	4.10958904109589	0.0319263033221413	0.0961310356389572	1	1	0.862010189697815	0.897626032864534	0.788427387744898
down	SREBF1; APOBR; LDLRAP1;	GO:0008203~cholesterol metabolic process	3	73	4.10958904109589	0.0319263033221413	0.0961310356389572	1	1	0.862010189697815	0.897626032864534	0.788427387744898
down	NCOR1; SREBF1; EP300;	GO:0007623~circadian rhythm	3	75	4	0.0341000764851924	0.0961310356389572	1	1	0.865381739248462	0.897626032864534	0.788427387744898
down	EP300; PPP1R13L; PPP1R13B; PRKAB1;	GO:1901796~regulation of signal transduction by p53 class mediator	4	131	3.05343511450382	0.0348666888602445	0.0961310356389572	1	1	0.868275992556985	0.897626032864534	0.788427387744898
down	CD74; LCK; ITGAX; PPIL2; SLC7A7;	GO:0050900~leukocyte migration	5	193	2.59067357512953	0.0349445852629927	0.0961310356389572	1	1	0.868275992556985	0.897626032864534	0.788427387744898
down	RASSF2; TCIRG1; RUNX3;	GO:0001503~ossification	3	76	3.94736842105263	0.0352150429389952	0.0961310356389572	1	1	0.868275992556985	0.897626032864534	0.788427387744898
down	SCN4B; SLC23A1; SLC13A4;	GO:0006814~sodium ion transport	3	77	3.8961038961039	0.0363486522756309	0.0971353671125541	1	1	0.871433359802647	0.897626032864534	0.796664503208128
down	CNOT1; EIF2AK2; DAPK1;	GO:0017148~negative regulation of translation	3	78	3.84615384615385	0.0375008419556664	0.100083733354953	1	1	0.871433359802647	0.897626032864534	0.820845795744499
down	SREBF1; EP300; SLC23A1;	GO:0030324~lung development	3	80	3.75	0.0398606938464151	0.104395830277014	1	1	0.876935264621132	0.897626032864534	0.856211848854883
down	SCN4B; CACNA1I; SLC23A1;	GO:0035725~sodium ion transmembrane transport	3	80	3.75	0.0398606938464151	0.104395830277014	1	1	0.876935264621132	0.897626032864534	0.856211848854883
down	XRCC2; INPP5B; NOTCH2; UNK; ZMIZ1;	GO:0001701~in utero embryonic development	5	203	2.46305418719212	0.0417224490190091	0.104395830277014	1	1	0.878695304467669	0.897626032864534	0.856211848854883
down	ERBB2; CYBA; INO80;	GO:0030307~positive regulation of cell growth	3	82	3.65853658536585	0.0422940263378475	0.104395830277014	1	1	0.882899588221103	0.897626032864534	0.856211848854883
down	RAF1; ERBB2; NOTCH2;	GO:0042060~wound healing	3	82	3.65853658536585	0.0422940263378475	0.104395830277014	1	1	0.882899588221103	0.897626032864534	0.856211848854883
down	HGS; UBAP1; MYO5B;	GO:0016197~endosomal transport	3	83	3.6144578313253	0.0435380540538861	0.104395830277014	1	1	0.882899588221103	0.897626032864534	0.856211848854883
